PROPE Severe Asthma Study in Egypt

Trial Identifier:	D3250R00122
Sponsor:	AstraZeneca
NCTID::	NCT06283290
Start Date:	March 2024
Primary Completion Date:	July 2024
Study Completion Date:	July 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Egypt, Alexandria	Alexandria, Egypt
Egypt, Cairo	Cairo, Egypt
Egypt, Dakahlia	Mansoura, Dakahlia, Egypt
Egypt, Sharkia	Zagazig, Sharkia, Egypt

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.